Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Physiol Res ; 54(4): 467-71, 2005.
Artigo em Inglês | MEDLINE | ID: mdl-16117602

RESUMO

We examined the effect of MCC-134, a novel inhibitor of mitochondrial ATP-sensitive K(+) (mitoK(ATP)) channels and activator of sarcolemmal ATP-sensitive K(+) (sarcK(ATP)) channels, on cardioprotection conferred by adaptation to chronic hypoxia. Adult male Wistar rats were exposed to intermittent hypobaric hypoxia (7000 m, 8 h/day, 5-6 weeks) and susceptibility of their hearts to ventricular arrhythmias and myocardial infarction was evaluated in anesthetized open-chest animals subjected to 20-min coronary artery occlusion and 3-h reperfusion on the day after the last hypoxic exposure. MCC-134 was administered intravenously 10 min before ischemia and 5 min before reperfusion in a total dose of 0.3 mg/kg or 3 mg/kg divided into two equal boluses. The infarct size (tetrazolium staining) was reduced from 59.2+/-4.4 % of the area at risk in normoxic controls to 43.2+/-3.3 % in the chronically hypoxic group. Chronic hypoxia decreased the reperfusion arrhythmia score from 2.4+/-0.5 in normoxic animals to 0.7+/-0.5. Both doses of MCC-134 completely abolished the antiarrhythmic protection (score 2.4+/-0.7 and 2.5+/-0.5, respectively) but only the high dose blocked the infarct size-limiting effect of chronic hypoxia (54.2+/-3.7 %). MCC-134 had no effect in the normoxic group. These results support the view that the opening of mitoKATP channels but not sarcKATP channels plays a crucial role in the mechanism by which chronic hypoxia improves cardiac tolerance to ischemia/reperfusion injury.


Assuntos
Transportadores de Cassetes de Ligação de ATP/agonistas , Adaptação Fisiológica/efeitos dos fármacos , Adaptação Fisiológica/fisiologia , Bloqueadores dos Canais de Cálcio/farmacologia , Hipóxia/fisiopatologia , Imidazóis/farmacologia , Mitocôndrias Cardíacas/efeitos dos fármacos , Traumatismo por Reperfusão Miocárdica/prevenção & controle , Canais de Potássio Corretores do Fluxo de Internalização/agonistas , Sarcolema/metabolismo , Tioamidas/farmacologia , Animais , Pressão Sanguínea/efeitos dos fármacos , Frequência Cardíaca/efeitos dos fármacos , Técnicas In Vitro , Canais KATP , Masculino , Infarto do Miocárdio/patologia , Infarto do Miocárdio/prevenção & controle , Traumatismo por Reperfusão Miocárdica/patologia , Ratos , Ratos Wistar , Sarcolema/efeitos dos fármacos
2.
Pediatr Res ; 38(6): 892-5, 1995 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-8618790

RESUMO

Cardiac malformations (pulmonary trunk stenosis, ventricular septal defect, and double outlet right ventricle) were induced by the administration of two doses of retinoic acid (RA) to Wistar rats on d 13 of pregnancy. Contractile performance of the isolated perfused rat heart and its inotropic response to Ca2+ (0.6-10.0 mmol.L-1) was studied in 20-d-old fetuses. The body weight of RA-exposed fetuses was significantly lower compared with controls. RA negatively influenced the contractile parameters of the fetal rat heart. The most pronounced effect was, except at a Ca2+ concentration of 2.5 mmol.L-1, observed at developed force at all other concentrations. Simultaneously, the sensitivity to Ca2+, expressed as the Ca2+ concentration at which 30% of maximum was attained, ws significantly lower in RA-exposed hearts. This implies that the malformed heart is more dependent on the extracellular sources of Ca2+.


Assuntos
Cálcio/farmacologia , Coração Fetal/efeitos dos fármacos , Contração Miocárdica/efeitos dos fármacos , Animais , Avaliação Pré-Clínica de Medicamentos , Feminino , Coração Fetal/anormalidades , Coração Fetal/metabolismo , Gravidez , Ratos , Ratos Wistar , Estimulação Química , Tretinoína
3.
Artigo em Inglês | MEDLINE | ID: mdl-2904868

RESUMO

1. After a single injection of 40 mg kg-1 of isoprenaline to the carp, lysophospholipids appear in the tissue of the heart ventricle, ethanolamine plasmalogens increase and choline plasmalogens decrease; phosphatidylinositol is lowered in the spongious layer only. 2. Daily administration of 5 mg kg-1 of the drug leads, after 5 doses, to a dramatic decrease of the diphosphatidylglycerol content; during the subsequent 5 and 10 doses a return to normal values occurs. Shifts in plasmalogens are similar to those found after a single high dose. Some other phospholipids change significantly. 3. All changes reveal that the spongious musculature is more sensitive to the drug than the compact one.


Assuntos
Carpas/metabolismo , Cyprinidae/metabolismo , Isoproterenol/farmacologia , Miocárdio/metabolismo , Fosfolipídeos/metabolismo , Animais , Peso Corporal/efeitos dos fármacos , Técnicas In Vitro , Plasmalogênios/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA